| Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study B Williams, J Howell, J Doyle, AJ Thompson, B Draper, C Layton, ... International Journal of Drug Policy 72, 91-98, 2019 | 56* | 2019 |
| Staying hepatitis C negative: a systematic review and meta‐analysis of cure and reinfection in people who inject drugs NH Latham, JS Doyle, AY Palmer, JW Vanhommerig, P Agius, ... Liver International 39 (12), 2244-2260, 2019 | 50 | 2019 |
| Community‐based, point‐of‐care hepatitis C testing: perspectives and preferences of people who inject drugs NH Latham, A Pedrana, JS Doyle, J Howell, B Williams, P Higgs, ... Journal of Viral Hepatitis 26 (7), 919-922, 2019 | 40 | 2019 |
| The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian … J Howell, MW Traeger, B Williams, C Layton, JS Doyle, N Latham, ... Journal of Viral Hepatitis 29 (5), 375-384, 2022 | 14 | 2022 |
| Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure M Stoové, J Wallace, P Higgs, A Pedrana, S Goutzamanis, N Latham, ... The International Journal of Drug Policy 75, 102596, 2020 | 8 | 2020 |
| “It's time!”: A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C S Walker, J Wallace, N Latham, F Saich, A Pedrana, M Hellard, C Treloar, ... International Journal of Drug Policy 97, 103280, 2021 | 3 | 2021 |
| Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis SC Munari, MW Traeger, V Menon, NH Latham, L Manoharan, ... Liver International 43 (12), 2625-2644, 2023 | 1 | 2023 |
| Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis L Manoharan, NH Latham, SC Munari, MW Traeger, V Menon, ... Hepatology Communications 7 (4), e0082, 2023 | 1 | 2023 |
| Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia MM Lahra, NH Latham, DJ Templeton, P Read, C Carmody, N Ryder, ... Communicable Diseases Intelligence 48, 2024 | | 2024 |
| Trends in viral hepatitis and hepatocellular carcinoma in New York City, 2001–2018 NH Latham, H Anger, A Bocour, B Qiao, T Insaf, TD McPherson Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2119, 2023 | | 2023 |
| Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA MK Lash, NH Latham, PY Chan, MMK Foote, EA Garcia, MF Silverstein, ... Emerging Infectious Diseases 29 (11), 2353, 2023 | | 2023 |
